Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research.
- DOI
- 10.1016/j.rpth.2025.102717
- Published
- 2025 Feb
- Container
- Research and practice in thrombosis and haemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rpth.2025.102717,
title = {Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research.},
author = {Brands MR and Taal EM and Voshaar MO and Driessens MHE and van Veen CME and Kruip MJHA and den Exter PL and Laros-van Gorkom BAP and Stein-Wit MA and Fischer K and Meijer S and Meijer K and Beijlevelt M and Fijnvandraat K and Gouw SC},
year = {2025},
journal = {Research and practice in thrombosis and haemostasis},
doi = {10.1016/j.rpth.2025.102717},
url = {https://doi.org/10.1016/j.rpth.2025.102717}
}RIS
TY - JOUR TI - Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research. AU - Brands MR AU - Taal EM AU - Voshaar MO AU - Driessens MHE AU - van Veen CME AU - Kruip MJHA AU - den Exter PL AU - Laros-van Gorkom BAP AU - Stein-Wit MA AU - Fischer K AU - Meijer S AU - Meijer K AU - Beijlevelt M AU - Fijnvandraat K AU - Gouw SC PY - 2025 JO - Research and practice in thrombosis and haemostasis DO - 10.1016/j.rpth.2025.102717 UR - https://doi.org/10.1016/j.rpth.2025.102717 ER -
APA
MR, B., EM, T., MO, V., MHE, D., CME, V. V., MJHA, K., PL, D. E., BAP, L. G., MA, S., K, F., S, M., K, M., M, B., K, F., & SC, G. (2025). Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research.. Research and practice in thrombosis and haemostasis. https://doi.org/10.1016/j.rpth.2025.102717
Source records
- pubmed · retrieved 2026-09-27T15:59:00.724Z